Moody Aldrich Partners »

Aeglea Biotherapeutics shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 43k 88.78

More positions owned by Moody Aldrich Partners

Element Solutions (ESI)
Oruka Therapeutics (ORKA)
Independent Bank (INDB)
Wintrust Financial Corporation (WTFC)
Ligand Pharmaceuticals Com New (LGND)
Old National Ban (ONB)
Columbia Banking System (COLB)
Riot Blockchain (RIOT)
Meta Financial (CASH)
Core Scientific (CORZ)
Protagonist Therapeutics (PTGX)
Dianthus Therapeutics (DNTH)
Cipher Mining (CIFR)
Ambiq Micro Common Stock (AMBQ)
Hut 8 Corp (HUT)

View all positions for Moody Aldrich Partners

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics